NCT02934477View on ClinicalTrials.gov

Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

RecruitingOBSERVATIONAL
Enrollment

650

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2026

Study Completion Date

October 31, 2027

Conditions
Myelofibrosis
Interventions
OTHER

Hematopoietic Stem Cell Transplant

This observational study will compare outcomes of prospectively enrolled HCT recipients with outcomes of a cohort of age-matched non-HCT controls.

Trial Locations (1)

55401

RECRUITING

Center for International Blood and Marrow Transplant Research, Minneapolis

All Listed Sponsors
collaborator

National Marrow Donor Program

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Center for International Blood and Marrow Transplant Research

NETWORK